160 related articles for article (PubMed ID: 6189653)
1. Androgen receptors.
Berkovitz GD; Brown TR; Migeon CJ
Clin Endocrinol Metab; 1983 Mar; 12(1):155-73. PubMed ID: 6189653
[TBL] [Abstract][Full Text] [Related]
2. Studies of gonadotropin-gonadal dynamics in patients with androgen insensitivity.
Boyar RM; Moore RJ; Rosner W; Aiman J; Chipman J; Madden JD; Marks JF; Griffin JE
J Clin Endocrinol Metab; 1978 Nov; 47(5):1116-22. PubMed ID: 122420
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of androgen insensitivity.
Brinkmann AO
Mol Cell Endocrinol; 2001 Jun; 179(1-2):105-9. PubMed ID: 11420135
[TBL] [Abstract][Full Text] [Related]
4. Correlation of clinical, endocrine and molecular abnormalities with in vivo responses to high-dose testosterone in patients with partial androgen insensitivity syndrome.
Tincello DG; Saunders PT; Hodgins MB; Simpson NB; Edwards CR; Hargreaves TB; Wu FC
Clin Endocrinol (Oxf); 1997 Apr; 46(4):497-506. PubMed ID: 9196614
[TBL] [Abstract][Full Text] [Related]
5. Male patients with partial androgen insensitivity syndrome: a longitudinal follow-up of growth, reproductive hormones and the development of gynaecomastia.
Hellmann P; Christiansen P; Johannsen TH; Main KM; Duno M; Juul A
Arch Dis Child; 2012 May; 97(5):403-9. PubMed ID: 22412043
[TBL] [Abstract][Full Text] [Related]
6. Analysis of a mutant androgen receptor offers a treatment modality in a patient with partial androgen insensitivity syndrome.
Radmayr C; Culig Z; Hobisch A; Corvin S; Bartsch G; Klocker H
Eur Urol; 1998; 33(2):222-6. PubMed ID: 9519369
[TBL] [Abstract][Full Text] [Related]
7. Role of the androgen receptor in male sexual differentiation.
Batch JA; Williams DM; Davies HR; Brown BD; Evans BA; Hughes IA; Patterson MN
Horm Res; 1992; 38(5-6):226-9. PubMed ID: 1307741
[TBL] [Abstract][Full Text] [Related]
8. Clinical, hormonal, behavioral, and genetic characteristics of androgen insensitivity syndrome in a Brazilian cohort: five novel mutations in the androgen receptor gene.
Melo KF; Mendonca BB; Billerbeck AE; Costa EM; Inácio M; Silva FA; Leal AM; Latronico AC; Arnhold IJ
J Clin Endocrinol Metab; 2003 Jul; 88(7):3241-50. PubMed ID: 12843171
[TBL] [Abstract][Full Text] [Related]
9. Male pseudohermaphroditism due to partial end-organ insensitivity to androgens.
Barragry JM; Makin HL; Morris DV; Trafford DJ; Mason AS
Clin Endocrinol (Oxf); 1977 Aug; 7(2):137-41. PubMed ID: 890997
[TBL] [Abstract][Full Text] [Related]
10. Incomplete testicular feminization syndrome: studies on androgen receptor(AR) function, AR gene analysis, and aromatase activities at puberty and long-term observations of clinical and hormonal features from infancy to puberty.
Isurugi K; Hasegawa F; Shibahara N; Mori H; Shima H; Harada N; Hasegawa T; Honma S; Imasaki K; Nawata H
Endocr J; 1996 Oct; 43(5):557-64. PubMed ID: 8980896
[TBL] [Abstract][Full Text] [Related]
11. The frequency of androgen receptor deficiency in infertile men.
Aiman J; Griffin JE
J Clin Endocrinol Metab; 1982 Apr; 54(4):725-32. PubMed ID: 6801070
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of natural and synthetic ligands for determining androgen receptors in prostatic tumors and prostatic nodular hyperplasia].
Kushlinskiĭ NR; Bassalyk LS; Degtiar' VG
Med Radiol (Mosk); 1983 Aug; 28(8):13-6. PubMed ID: 6193390
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor assay in human benign and malignant prostatic tumour cytosol using protamine sulphate precipitation.
Mobbs BG; Johnson IE; Connolly JG; Clark AF
J Steroid Biochem; 1978 Apr; 9(4):289-301. PubMed ID: 77938
[No Abstract] [Full Text] [Related]
14. [Hormone-dependency of the human prostate].
Robel P
Bull Cancer; 1986; 73(1):19-22. PubMed ID: 2430651
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptors and partial androgen insensitivity in male pseudohermaphroditism.
Sultan C
Ann Genet; 1986; 29(1):5-10. PubMed ID: 3521447
[TBL] [Abstract][Full Text] [Related]
16. Partial androgen insensitivity: the Reifenstein syndrome revisited.
Amrhein JA; Klingensmith GJ; Walsh PC; McKusick VA; Migeon CJ
N Engl J Med; 1977 Aug; 297(7):350-6. PubMed ID: 876326
[TBL] [Abstract][Full Text] [Related]
17. Human prostatic carcinoma: significant differences in its androgen binding and metabolism compared to the human benign prostatic hypertrophy.
Krieg M; Grobe I; Voight KD; Altenähr E; Klosterhalfen H
Acta Endocrinol (Copenh); 1978 Jun; 88(2):397-407. PubMed ID: 78653
[No Abstract] [Full Text] [Related]
18. High dose androgen therapy in male pseudohermaphroditism due to 5 alpha-reductase deficiency and disorders of the androgen receptor.
Price P; Wass JA; Griffin JE; Leshin M; Savage MO; Large DM; Bu'Lock DE; Anderson DC; Wilson JD; Besser GM
J Clin Invest; 1984 Oct; 74(4):1496-508. PubMed ID: 6480833
[TBL] [Abstract][Full Text] [Related]
19. Human complete androgen insensitivity with normal dihydrotestosterone receptor binding capacity in cultured genital skin fibroblasts: evidence for a qualitative abnormality of the receptor.
Brown TR; Maes M; Rothwell SW; Migeon CJ
J Clin Endocrinol Metab; 1982 Jul; 55(1):61-9. PubMed ID: 7076808
[TBL] [Abstract][Full Text] [Related]
20. Puberty in subjects with complete androgen insensitivity syndrome.
Papadimitriou DT; Linglart A; Morel Y; Chaussain JL
Horm Res; 2006; 65(3):126-31. PubMed ID: 16491011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
